Clinical Trial: A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879132) titled 'A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions' on March 11.

Brief Summary: The purpose of this clinical study is to evaluate the pharmacokinetics and safety of BR3409 and co-administration of BR3409-1 and BR3409-2 in healthy volunteers Under Fed Conditions

Study Start Date: Nov. 05, 2024

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: BR3409

One tablet administered alone

DRUG: BR3409-1

One tablet administered alone

DRUG: BR3409-2

One tablet administered alone

Recruitment Status: COMPLETED ...